Pay in 4 interest-free payments of $7.26 Learn more
Ships within 48 hours · Estimated delivery Sep 4 - Sep 9
The current evidence base points to several overlapping molecular pathways operating in parallel: VEGFR2/Akt/eNOS Angiogenic Signalling A primary mechanistic axis involves upregulation of vascular endothelial growth factor receptor 2 (VEGFR2), leading to activation of the Akt/eNOS (endothelial nitric oxide synthase) downstream pathway
Factors to Discuss with Your Doctor Current Nutrient Status: Your doctor can help determine if your body actually needs additional antioxidant support based on your diet and lifestyle
The dual-pathway stimulation of this growth hormone releasing peptide combination generates more robust GH pulses that affect a wider range of tissue and systems
$50.00 $100.00Price range: $50.00 through $100.00 AOD-9604 is supplied as a research peptide in a sealed sterile glass vial
Govindarajan A, Bistas KG, Ingold CJ, Patel P, Aboeed A
Because chronic illnesses are highly individualized and often involve multiple overlapping system dysfunctions, your treatment approach must be highly personalized as well
US$ 29.19
US$ 28.68
US$ 21.72
US$ 27.87
US$ 21.34
US$ 29.38
